MGNX
MacroGenics Inc
3.70$
-1.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -339.0% | -261.5% | -501.4% | -412.0% | 54.3% | -216.6% | -355.4% | -211.3% | -41.4% | 104.4% | -172.4% | -124.1% | -38.0% | |
| 18.8% | 17.7% | 20.2% | 16.8% | 1.7% | 11.6% | 13.4% | 8.6% | 2.5% | 3.8% | 8.1% | -1.4% | 2.7% | |
| 46.1% | 40.7% | 61.0% | 61.6% | 5.4% | 63.5% | 33.2% | 16.6% | 4.9% | 6.5% | 12.7% | 6.0% | 6.5% | |
| -58.0% | 93.4% | -1.6% | 28.0% | -3.7% | 14.8% | -92.7% | -76.5% | -71.7% | 128.9% | -8.5% | -54.0% | -11.1% | |
| 4.8% | 5.8% | 16.0% | 9.6% | 0.5% | 3.5% | 4.0% | 3.2% | 0.6% | 0.6% | 1.7% | 2.5% | 1.1% | |
| -322.4% | 362.1% | 272.3% | 439.4% | 32.2% | 233.9% | 75.1% | -169.2% | -28.0% | -160.1% | 218.1% | 85.2% | -7.8% | |
| – | 0.6% | – | – | – | – | – | – | – | – | – | – | – | |
| -1.4% | 2.9% | – | – | – | – | -2.1% | – | – | – | – | – | – | |
| 480.1% | 2.5% | 2.7% | 5.8% | -0.1% | 0.9% | -2.1% | 313.6% | 0.0% | 0.1% | -1.0% | 183.3% | 35.8% | |
| -181.4% | 103.2% | -226.3% | 33.1% | 86.4% | 18.1% | -282.5% | -66.9% | -69.4% | -55.6% | 44.8% | 144.3% | -10.0% | |
| -343.8% | -267.3% | -517.4% | -421.6% | 53.8% | -220.1% | -359.5% | -214.5% | -42.0% | 103.8% | -174.0% | -126.6% | -39.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.